Showing results (81-90 of 135) with videos related to

Sort By:
Pageof 14
Cancer Research Communications|December 4, 2025
SM08502-Mediated β-Catenin Repression Synergizes with Olaparib to Inhibit Tumor ProgressionBradley R Corr, Elizabeth R Woodruff, Tomomi M Yamamoto, et al.
Nature Communications|March 21, 2024
Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomasMarina T Broz, Emily Y Ko, Kristin Ishaya, et al.
Cancer Biology & Therapy|December 7, 2007
Mechanisms of Cables 1 gene inactivation in human ovarian cancer developmentHideo Sakamoto, Anne M Friel, Antony W Wood, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Ablation of hematopoietic stem cell derived adipocytes reduces tumor burden in syngeneic mouse models of high-grade serous carcinomaElizabeth R Woodruff, Courtney A Bailey, Francis To, et al.
European Journal of Cancer (Oxford, England : 1990)|March 30, 2025
Artificial intelligence-based virtual staining platform for identifying tumor-associated macrophages from hematoxylin and eosin-stained imagesArpit Aggarwal, Mayukhmala Jana, Amritpal Singh, et al.
Plos One|February 23, 2012
Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcomeDavid A Engler, Sumeet Gupta, Whitfield B Growdon, et al.
Journal of Hematology & Oncology|February 26, 2014
A novel mycobacterial Hsp70-containing fusion protein targeting mesothelin augments antitumor immunity and prolongs survival in murine models of ovarian cancer and mesotheliomaJianping Yuan, Satoshi Kashiwagi, Patrick Reeves, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 2, 2020
Targeting progesterone signaling prevents metastatic ovarian cancerOlga Kim, Eun Young Park, Sun Young Kwon, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Replication stress marker phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancerAngela Schab, Amanda Compadre, Rikki Drexler, et al.
The Journal of Clinical Investigation|May 20, 2025
Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancerAngela Schab, Amanda Compadre, Rebecca Drexler, et al.
Pageof 14